MALABRE RICHARD C (SVP, Chief Accounting Officer) sold 14.2% of their position (49.52K shares) of AKEBIA THERAPEUTICS, INC. on the open market
Open‑market sale worth $68.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/4/2026ACC: 0002007730-26-000002
Officer· SVP, Chief Accounting Officer
Since Feb 2026
-49.52K
Net shares
Net seller
$68.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
49.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−36.14K
Price / share
$1.39
Trade value
$50.24K
% of position
10.4%
2/2/2026
348.91K→312.77K
Common Stock
Direct
Shares
−13.38K
Price / share
$1.39
Trade value
$18.60K
% of position
4.3%
2/2/2026
312.77K→299.39K
Total
Net shares
−49.52K
Net value
-$68.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −36.14K | $1.39 | $50.24K | 10.4% | 348.91K | 312.77K |
| Common Stock Direct | 2/2/2026 | S · Sale | −13.38K | $1.39 | $18.60K | 4.3% | 312.77K | 299.39K |
| Total | −49.52K | -$68.84K | ||||||
Derivative Transactions0
No derivative transactions reported